QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
A phase 3 trial testing QLC5508 in oesophageal cancer, now recruiting.
Overview
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Oesophageal Squamous Cell Carcinoma is a phase 3 interventional study registered as NCT07463573, led by Qilu Pharmaceutical, and recruiting when checked on 2026-09-11. Official title: A Randomised, Open-Label, Multicenter Phase III Study of QLC5508 Versus Investigator's Choice Chemotherapy in Pretreated Participants With Advanced or Metastatic Oesophageal Squamous Cell Carcinoma (ESCC). Planned enrolment is 466 participants (estimated). The study started in 2026-04-20 and primary completion is expected in 2028-06-05. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialA Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Shares QLC5508, Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
Shares Qilu Pharmaceutical and the tag ctgov-ingest.
- TrialA Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
Shares Qilu Pharmaceutical and the tag ctgov-ingest.